Pub Date : 2021-01-01Epub Date: 2021-08-10DOI: 10.1007/s11424-020-0013-0
Pei Wang
Biological systems can be modeled and described by biological networks. Biological networks are typical complex networks with widely real-world applications. Many problems arising in biological systems can be boiled down to the identification of important nodes. For example, biomedical researchers frequently need to identify important genes that potentially leaded to disease phenotypes in animal and explore crucial genes that were responsible for stress responsiveness in plants. To facilitate the identification of important nodes in biological systems, one needs to know network structures or behavioral data of nodes (such as gene expression data). If network topology was known, various centrality measures can be developed to solve the problem; while if only behavioral data of nodes were given, some sophisticated statistical methods can be employed. This paper reviewed some of the recent works on statistical identification of important nodes in biological systems from three aspects, that is, 1) in general complex networks based on complex networks theory and epidemic dynamic models; 2) in biological networks based on network motifs; and 3) in plants based on RNA-seq data. The identification of important nodes in a complex system can be seen as a mapping from the system to the ranking score vector of nodes, such mapping is not necessarily with explicit form. The three aspects reflected three typical approaches on ranking nodes in biological systems and can be integrated into one general framework. This paper also proposed some challenges and future works on the related topics. The associated investigations have potential real-world applications in the control of biological systems, network medicine and new variety cultivation of crops.
{"title":"Statistical Identification of Important Nodes in Biological Systems.","authors":"Pei Wang","doi":"10.1007/s11424-020-0013-0","DOIUrl":"10.1007/s11424-020-0013-0","url":null,"abstract":"<p><p>Biological systems can be modeled and described by biological networks. Biological networks are typical complex networks with widely real-world applications. Many problems arising in biological systems can be boiled down to the identification of important nodes. For example, biomedical researchers frequently need to identify important genes that potentially leaded to disease phenotypes in animal and explore crucial genes that were responsible for stress responsiveness in plants. To facilitate the identification of important nodes in biological systems, one needs to know network structures or behavioral data of nodes (such as gene expression data). If network topology was known, various centrality measures can be developed to solve the problem; while if only behavioral data of nodes were given, some sophisticated statistical methods can be employed. This paper reviewed some of the recent works on statistical identification of important nodes in biological systems from three aspects, that is, 1) in general complex networks based on complex networks theory and epidemic dynamic models; 2) in biological networks based on network motifs; and 3) in plants based on RNA-seq data. The identification of important nodes in a complex system can be seen as a mapping from the system to the ranking score vector of nodes, such mapping is not necessarily with explicit form. The three aspects reflected three typical approaches on ranking nodes in biological systems and can be integrated into one general framework. This paper also proposed some challenges and future works on the related topics. The associated investigations have potential real-world applications in the control of biological systems, network medicine and new variety cultivation of crops.</p>","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"34 4","pages":"1454-1470"},"PeriodicalIF":2.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39314100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01Epub Date: 2022-01-11DOI: 10.1007/s11424-021-0008-5
Chen Fei, Weiyin Fei, Fanhong Zhang, Xiaoguang Yang
This paper studies the problem of principal-agent with moral hazard in continuous time. The firm's cash flow is described by geometric Brownian motion (hereafter GBM). The agent affects the drift of the firm's cash flow by her hidden effort. Meanwhile, the firm rewards the agent with corresponding compensation and equity which depend on the output. The model extends dynamic optimal contract theory to an inflation environment. Firstly, the authors obtain the dynamic equation of the firm's real cash flow under inflation by using the Itô formula. Then, the authors use the martingale representation theorem to obtain agent's continuation value process. Moreover, the authors derive the Hamilton-Jacobi-Bellman (HJB) equation of investor's value process, from which the authors derive the investors' scaled value function by solving the second-order ordinary differential equation. Comparing with He[1], the authors find that inflation risk affects the agent's optimal compensation depending on the firm's position in the market.
{"title":"Agent's Optimal Compensation Under Inflation Risk by Using Dynamic Contract Model.","authors":"Chen Fei, Weiyin Fei, Fanhong Zhang, Xiaoguang Yang","doi":"10.1007/s11424-021-0008-5","DOIUrl":"https://doi.org/10.1007/s11424-021-0008-5","url":null,"abstract":"<p><p>This paper studies the problem of principal-agent with moral hazard in continuous time. The firm's cash flow is described by geometric Brownian motion (hereafter GBM). The agent affects the drift of the firm's cash flow by her hidden effort. Meanwhile, the firm rewards the agent with corresponding compensation and equity which depend on the output. The model extends dynamic optimal contract theory to an inflation environment. Firstly, the authors obtain the dynamic equation of the firm's real cash flow under inflation by using the Itô formula. Then, the authors use the martingale representation theorem to obtain agent's continuation value process. Moreover, the authors derive the Hamilton-Jacobi-Bellman (HJB) equation of investor's value process, from which the authors derive the investors' scaled value function by solving the second-order ordinary differential equation. Comparing with He<sup>[1]</sup>, the authors find that inflation risk affects the agent's optimal compensation depending on the firm's position in the market.</p>","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"34 6","pages":"2291-2309"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39914987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01Epub Date: 2021-02-04DOI: 10.1007/s11424-021-0053-0
Anwarud Din, Yongjin Li, Murad Ali Shah
This paper proposes various stages of the hepatitis B virus (HBV) besides its transmissibility and nonlinear incidence rate to develop an epidemic model. The authors plan the model, and then prove some basic results for the well-posedness in term of boundedness and positivity. Moreover, the authors find the threshold parameter R0, called the basic/effective reproductive number and carry out local sensitive analysis. Furthermore, the authors examine stability and hence condition for stability in terms of R0. By using sensitivity analysis, the authors formulate a control problem in order to eradicate HBV from the population and proved that the control problem actually exists. The complete characterization of the optimum system was achieved by using the 4th-order Runge-Kutta procedure.
{"title":"The Complex Dynamics of Hepatitis B Infected Individuals with Optimal Control.","authors":"Anwarud Din, Yongjin Li, Murad Ali Shah","doi":"10.1007/s11424-021-0053-0","DOIUrl":"https://doi.org/10.1007/s11424-021-0053-0","url":null,"abstract":"<p><p>This paper proposes various stages of the hepatitis B virus (HBV) besides its transmissibility and nonlinear incidence rate to develop an epidemic model. The authors plan the model, and then prove some basic results for the well-posedness in term of boundedness and positivity. Moreover, the authors find the threshold parameter <i>R</i> <sub>0</sub>, called the basic/effective reproductive number and carry out local sensitive analysis. Furthermore, the authors examine stability and hence condition for stability in terms of <i>R</i> <sub>0</sub>. By using sensitivity analysis, the authors formulate a control problem in order to eradicate HBV from the population and proved that the control problem actually exists. The complete characterization of the optimum system was achieved by using the 4<sup>th</sup>-order Runge-Kutta procedure.</p>","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"34 4","pages":"1301-1323"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11424-021-0053-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25351230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jilma Alemán-Laporte, Gilbert Alvarado, Mariana Sa Garcia-Gomes, Ana Tada Fonseca Brasil Antiorio, Marco Zúñiga-Montero, Claudia Madalena Cabrera Mori
Over the last two decades, pigs have become animal biomodels widely used for the investigation and practice of surgical techniques because of their great physiological and anatomical similarities to humans. Even though many of these studies must be carried out later in humans, the description of basic information is limited, making exact repetitions of the reported experimental methods impossible. In this review, 108 studies from 2013 to 2018 were considered to determine the quality of adherence to the ARRIVE guidelines in the reports of the methodologies. The majority of the studies lacked the details recommended in the ARRIVE guidelines regarding data directly related to the welfare of animals undergoing surgery and those about anesthetic protocols and analgesics. Information related to sample size calculation and housing and husbandry conditions was also very limited. We believe that the ARRIVE guidelines are an excellent tool for good-quality reporting. We encourage scientists to consistently use them as a tool to improve the quality of their scientific reports and, consequently, ensure animal welfare.
{"title":"Quality of Adherence to the ARRIVE Guidelines in the Material and Methods Section in Studies Where Swine Were Used as Surgical Biomodels: A Systematic Review (2013-2018).","authors":"Jilma Alemán-Laporte, Gilbert Alvarado, Mariana Sa Garcia-Gomes, Ana Tada Fonseca Brasil Antiorio, Marco Zúñiga-Montero, Claudia Madalena Cabrera Mori","doi":"10.3390/ani9110947","DOIUrl":"10.3390/ani9110947","url":null,"abstract":"<p><p>Over the last two decades, pigs have become animal biomodels widely used for the investigation and practice of surgical techniques because of their great physiological and anatomical similarities to humans. Even though many of these studies must be carried out later in humans, the description of basic information is limited, making exact repetitions of the reported experimental methods impossible. In this review, 108 studies from 2013 to 2018 were considered to determine the quality of adherence to the ARRIVE guidelines in the reports of the methodologies. The majority of the studies lacked the details recommended in the ARRIVE guidelines regarding data directly related to the welfare of animals undergoing surgery and those about anesthetic protocols and analgesics. Information related to sample size calculation and housing and husbandry conditions was also very limited. We believe that the ARRIVE guidelines are an excellent tool for good-quality reporting. We encourage scientists to consistently use them as a tool to improve the quality of their scientific reports and, consequently, ensure animal welfare.</p>","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"35 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2019-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912630/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74608965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-12-10Epub Date: 2016-11-16DOI: 10.1016/S0140-6736(16)31275-2
Serge Gauthier, Howard H Feldman, Lon S Schneider, Gordon K Wilcock, Giovanni B Frisoni, Jiri H Hardlund, Hans J Moebius, Peter Bentham, Karin A Kook, Damon J Wischik, Bjoern O Schelter, Charles S Davis, Roger T Staff, Luc Bracoud, Kohkan Shamsi, John M D Storey, Charles R Harrington, Claude M Wischik
<p><strong>Background: </strong>Leuco-methylthioninium bis(hydromethanesulfonate; LMTM), a stable reduced form of the methylthioninium moiety, acts as a selective inhibitor of tau protein aggregation both in vitro and in transgenic mouse models. Methylthioninium chloride has previously shown potential efficacy as monotherapy in patients with Alzheimer's disease. We aimed to determine whether LMTM was safe and effective in modifying disease progression in patients with mild to moderate Alzheimer's disease.</p><p><strong>Methods: </strong>We did a 15-month, randomised, controlled double-blind, parallel-group trial at 115 academic centres and private research clinics in 16 countries in Europe, North America, Asia, and Russia with patients younger than 90 years with mild to moderate Alzheimer's disease. Patients concomitantly using other medicines for Alzheimer's disease were permitted to be included because we considered it infeasible not to allow their inclusion; however, patients using medicines carrying warnings of methaemoglobinaemia were excluded because the oxidised form of methylthioninium in high doses has been shown to induce this condition. We randomly assigned participants (3:3:4) to 75 mg LMTM twice a day, 125 mg LMTM twice a day, or control (4 mg LMTM twice a day to maintain blinding with respect to urine or faecal discolouration) administered as oral tablets. We did the randomisation with an interactive web response system using 600 blocks of length ten, and stratified patients by severity of disease, global region, whether they were concomitantly using Alzheimer's disease-labelled medications, and site PET capability. Participants, their study partners (generally carers), and all assessors were masked to treatment assignment throughout the study. The coprimary outcomes were progression on the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) and the Alzheimer's Disease Co-operative Study-Activities of Daily Living Inventory (ADCS-ADL) scales from baseline assessed at week 65 in the modified intention-to-treat population. This trial is registered with Clinicaltrials.gov (NCT01689246) and the European Union Clinical Trials Registry (2012-002866-11).</p><p><strong>Findings: </strong>Between Jan 29, 2013, and June 26, 2014, we recruited and randomly assigned 891 participants to treatment (357 to control, 268 to 75 mg LMTM twice a day, and 266 to 125 mg LMTM twice a day). The prespecified primary analyses did not show any treatment benefit at either of the doses tested for the coprimary outcomes (change in ADAS-Cog score compared with control [n=354, 6·32, 95% CI 5·31-7·34]: 75 mg LMTM twice a day [n=257] -0·02, -1·60 to 1·56, p=0·9834, 125 mg LMTM twice a day [n=250] -0·43, -2·06 to 1·20, p=0·9323; change in ADCS-ADL score compared with control [-8·22, 95% CI -9·63 to -6·82]: 75 mg LMTM twice a day -0·93, -3·12 to 1·26, p=0·8659; 125 mg LMTM twice a day -0·34, -2·61 to 1·93, p=0·9479). Gastrointestinal and urinary effects
{"title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.","authors":"Serge Gauthier, Howard H Feldman, Lon S Schneider, Gordon K Wilcock, Giovanni B Frisoni, Jiri H Hardlund, Hans J Moebius, Peter Bentham, Karin A Kook, Damon J Wischik, Bjoern O Schelter, Charles S Davis, Roger T Staff, Luc Bracoud, Kohkan Shamsi, John M D Storey, Charles R Harrington, Claude M Wischik","doi":"10.1016/S0140-6736(16)31275-2","DOIUrl":"10.1016/S0140-6736(16)31275-2","url":null,"abstract":"<p><strong>Background: </strong>Leuco-methylthioninium bis(hydromethanesulfonate; LMTM), a stable reduced form of the methylthioninium moiety, acts as a selective inhibitor of tau protein aggregation both in vitro and in transgenic mouse models. Methylthioninium chloride has previously shown potential efficacy as monotherapy in patients with Alzheimer's disease. We aimed to determine whether LMTM was safe and effective in modifying disease progression in patients with mild to moderate Alzheimer's disease.</p><p><strong>Methods: </strong>We did a 15-month, randomised, controlled double-blind, parallel-group trial at 115 academic centres and private research clinics in 16 countries in Europe, North America, Asia, and Russia with patients younger than 90 years with mild to moderate Alzheimer's disease. Patients concomitantly using other medicines for Alzheimer's disease were permitted to be included because we considered it infeasible not to allow their inclusion; however, patients using medicines carrying warnings of methaemoglobinaemia were excluded because the oxidised form of methylthioninium in high doses has been shown to induce this condition. We randomly assigned participants (3:3:4) to 75 mg LMTM twice a day, 125 mg LMTM twice a day, or control (4 mg LMTM twice a day to maintain blinding with respect to urine or faecal discolouration) administered as oral tablets. We did the randomisation with an interactive web response system using 600 blocks of length ten, and stratified patients by severity of disease, global region, whether they were concomitantly using Alzheimer's disease-labelled medications, and site PET capability. Participants, their study partners (generally carers), and all assessors were masked to treatment assignment throughout the study. The coprimary outcomes were progression on the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) and the Alzheimer's Disease Co-operative Study-Activities of Daily Living Inventory (ADCS-ADL) scales from baseline assessed at week 65 in the modified intention-to-treat population. This trial is registered with Clinicaltrials.gov (NCT01689246) and the European Union Clinical Trials Registry (2012-002866-11).</p><p><strong>Findings: </strong>Between Jan 29, 2013, and June 26, 2014, we recruited and randomly assigned 891 participants to treatment (357 to control, 268 to 75 mg LMTM twice a day, and 266 to 125 mg LMTM twice a day). The prespecified primary analyses did not show any treatment benefit at either of the doses tested for the coprimary outcomes (change in ADAS-Cog score compared with control [n=354, 6·32, 95% CI 5·31-7·34]: 75 mg LMTM twice a day [n=257] -0·02, -1·60 to 1·56, p=0·9834, 125 mg LMTM twice a day [n=250] -0·43, -2·06 to 1·20, p=0·9323; change in ADCS-ADL score compared with control [-8·22, 95% CI -9·63 to -6·82]: 75 mg LMTM twice a day -0·93, -3·12 to 1·26, p=0·8659; 125 mg LMTM twice a day -0·34, -2·61 to 1·93, p=0·9479). Gastrointestinal and urinary effects","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"29 1","pages":"2873-2884"},"PeriodicalIF":0.0,"publicationDate":"2016-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5164296/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74587871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-01-01Epub Date: 2011-06-11DOI: 10.1007/s11424-011-8252-8
Haifeng Zhang, Michael Small, Xinchu Fu
In this paper, epidemic spread with the staged progression model on homogeneous and heterogeneous networks is studied. First, the epidemic threshold of the simple staged progression model is given. Then the staged progression model with birth and death is also considered. The case where infectivity is a nonlinear function of the nodes' degree is discussed, too. Finally, the analytical results are verified by numerical simulations.
{"title":"Staged progression model for epidemic spread on homogeneous and heterogeneous networks.","authors":"Haifeng Zhang, Michael Small, Xinchu Fu","doi":"10.1007/s11424-011-8252-8","DOIUrl":"10.1007/s11424-011-8252-8","url":null,"abstract":"<p><p>In this paper, epidemic spread with the staged progression model on homogeneous and heterogeneous networks is studied. First, the epidemic threshold of the simple staged progression model is given. Then the staged progression model with birth and death is also considered. The case where infectivity is a nonlinear function of the nodes' degree is discussed, too. Finally, the analytical results are verified by numerical simulations.</p>","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"24 4","pages":"619"},"PeriodicalIF":2.1,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089252/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37773159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2010-10-01Epub Date: 2010-11-09DOI: 10.1007/s11424-010-0213-0
Youfang Cao, Jie Liang
Langevin equation is widely used to study the stochastic effects in molecular networks, as it often approximates well the underlying chemical master equation. However, frequently it is not clear when such an approximation is applicable and when it breaks down. This paper studies the simple Schnakenberg model consisting of three reversible reactions and two molecular species whose concentrations vary. To reduce the residual errors from the conventional formulation of the Langevin equation, the authors propose to explicitly model the effective coupling between macroscopic concentrations of different molecular species. The results show that this formulation is effective in correcting residual errors from the original uncoupled Langevin equation and can approximate the underlying chemical master equation very accurately.
{"title":"NONLINEAR LANGEVIN MODEL WITH PRODUCT STOCHASTICITY FOR BIOLOGICAL NETWORKS: THE CASE OF THE SCHNAKENBERG MODEL.","authors":"Youfang Cao, Jie Liang","doi":"10.1007/s11424-010-0213-0","DOIUrl":"https://doi.org/10.1007/s11424-010-0213-0","url":null,"abstract":"<p><p>Langevin equation is widely used to study the stochastic effects in molecular networks, as it often approximates well the underlying chemical master equation. However, frequently it is not clear when such an approximation is applicable and when it breaks down. This paper studies the simple Schnakenberg model consisting of three reversible reactions and two molecular species whose concentrations vary. To reduce the residual errors from the conventional formulation of the Langevin equation, the authors propose to explicitly model the effective coupling between macroscopic concentrations of different molecular species. The results show that this formulation is effective in correcting residual errors from the original uncoupled Langevin equation and can approximate the underlying chemical master equation very accurately.</p>","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"23 5","pages":"896-905"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11424-010-0213-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34899274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I. Lazar, B. Pârv, S. Motogna, I. Czibula, Codrut-Lucian Lazar
Agile Model Driven Architecture (MDA) software development processes apply agile principles in the context of executable models. In this paper we present an agile MDA approach for constructing, running, and testing executable UML service-oriented components. This work is part of a series referring to COMDEVALCO - a framework for Software Component Definition, Validation, and Composition.
{"title":"An Agile MDA Approach for the Development of Service-Oriented Component-Based Applications","authors":"I. Lazar, B. Pârv, S. Motogna, I. Czibula, Codrut-Lucian Lazar","doi":"10.1109/CANS.2008.12","DOIUrl":"https://doi.org/10.1109/CANS.2008.12","url":null,"abstract":"Agile Model Driven Architecture (MDA) software development processes apply agile principles in the context of executable models. In this paper we present an agile MDA approach for constructing, running, and testing executable UML service-oriented components. This work is part of a series referring to COMDEVALCO - a framework for Software Component Definition, Validation, and Composition.","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"396 1","pages":"38-44"},"PeriodicalIF":2.1,"publicationDate":"2008-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88970054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In this paper a new Chaotic Neural Network (CNN) have been made. This network contains desired number of interacting units and each one has its own chaotic dynamic and strange attractor caused by creating convex hull among output units. Having a special interaction characteristic, the model is able to create enormous different chaotic behaviors. Lyapunov Exponent and phase space plane criteria have been used for demonstrating discrimination between behaviors. Making use of convex hull for trapping generated outputs of each unit in subsequent iteration, its folding characteristic and stretching property of logistic function, emerging of arbitrary number of various strange attractors have been accomplished. Therefore, based on desired criterion, this network is able to assign each strange attractor to each sensory input. In other words the network has the ability of being a candidate for modeling perception.
{"title":"A Heuristic Chaotic Neural Network: Candidate Model for Perception","authors":"M. Ahmadlou, F. Mamashli, M. Golpayegani","doi":"10.1109/CANS.2008.18","DOIUrl":"https://doi.org/10.1109/CANS.2008.18","url":null,"abstract":"In this paper a new Chaotic Neural Network (CNN) have been made. This network contains desired number of interacting units and each one has its own chaotic dynamic and strange attractor caused by creating convex hull among output units. Having a special interaction characteristic, the model is able to create enormous different chaotic behaviors. Lyapunov Exponent and phase space plane criteria have been used for demonstrating discrimination between behaviors. Making use of convex hull for trapping generated outputs of each unit in subsequent iteration, its folding characteristic and stretching property of logistic function, emerging of arbitrary number of various strange attractors have been accomplished. Therefore, based on desired criterion, this network is able to assign each strange attractor to each sensory input. In other words the network has the ability of being a candidate for modeling perception.","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"875 1","pages":"85-93"},"PeriodicalIF":2.1,"publicationDate":"2008-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72662672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Certain threshold on network size axis was observed in statistical mechanisms of adaptive evolution. Now it is investigated. This threshold is connected with maturation of chaos and lies far above the critical point of percolation. It can be treated as complexity threshold defining the term 'complex network' for Kauffman chaotic networks. Distributions of damage size are obtained using simulation for a representative set of network parameters and network types (including scale-free, RBN and networks with more than two signal variants) for network sizes up to 4000 nodes. Based on them a criterion of the threshold is sought. We do not find any critical point in the investigated area, however a certain practical criterion is proposed. It is zero occurrence in-between two peaks of damage size frequency - left of real fadeout of damage which is ordered behaviour and right of equilibrium level after damage avalanche which is chaotic behaviour.
{"title":"A Certain Complexity Threshold during Growth of Functioning Networks","authors":"A. Gecow","doi":"10.1109/CANS.2008.16","DOIUrl":"https://doi.org/10.1109/CANS.2008.16","url":null,"abstract":"Certain threshold on network size axis was observed in statistical mechanisms of adaptive evolution. Now it is investigated. This threshold is connected with maturation of chaos and lies far above the critical point of percolation. It can be treated as complexity threshold defining the term 'complex network' for Kauffman chaotic networks. Distributions of damage size are obtained using simulation for a representative set of network parameters and network types (including scale-free, RBN and networks with more than two signal variants) for network sizes up to 4000 nodes. Based on them a criterion of the threshold is sought. We do not find any critical point in the investigated area, however a certain practical criterion is proposed. It is zero occurrence in-between two peaks of damage size frequency - left of real fadeout of damage which is ordered behaviour and right of equilibrium level after damage avalanche which is chaotic behaviour.","PeriodicalId":50026,"journal":{"name":"Journal of Systems Science & Complexity","volume":"47 1","pages":"69-76"},"PeriodicalIF":2.1,"publicationDate":"2008-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91256861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}